1. Home
  2. ATNM vs BDL Comparison

ATNM vs BDL Comparison

Compare ATNM & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.16

Market Cap

36.8M

Sector

Health Care

ML Signal

N/A

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

N/A

Current Price

$33.83

Market Cap

62.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
ATNM
BDL
Founded
2000
1959
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
36.8M
62.6M
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
ATNM
BDL
Price
$1.16
$33.83
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
103.3K
534.0
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
1.65%
EPS Growth
30.60
49.72
EPS
N/A
0.43
Revenue
$81,000.00
$205,248,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$77.55
Revenue Growth
N/A
8.99
52 Week Low
$1.02
$22.61
52 Week High
$1.95
$35.98

Technical Indicators

Market Signals
Indicator
ATNM
BDL
Relative Strength Index (RSI) 44.08 54.70
Support Level $1.02 $29.56
Resistance Level $1.25 $34.61
Average True Range (ATR) 0.07 0.25
MACD 0.01 0.04
Stochastic Oscillator 41.86 91.25

Price Performance

Historical Comparison
ATNM
BDL

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

Share on Social Networks: